| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 7e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |